Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Status:
Recruiting
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate epacadostat when given with routine
radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer
before routine surgery is performed to remove the tumor.